XML 72 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Changes in Stockholders’ Equity (Unaudited ) - USD ($)
$ in Thousands
Common Stock
Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Deficit
Treasury Shares
Total
Balance at the beginning of the period at Dec. 31, 2017 $ 387 $ 606,346 $ 19,297 $ (249,847) $ (200) $ 375,983
Increase (decrease) in Stockholders' Equity            
Stock based employee compensation plan   238       238
New unrealized gain (loss) on investment securities, net of deferred tax expense (benefit)     (21,459)     (21,459)
Net income       10,795   10,795
Balance at the end of the period at Mar. 31, 2018 387 606,584 (2,162) (239,052) (200) 365,557
Balance at the beginning of the period at Dec. 31, 2017 387 606,346 19,297 (249,847) (200) 375,983
Increase (decrease) in Stockholders' Equity            
Net income           40,423
Balance at the end of the period at Sep. 30, 2018 387 606,905 (13,949) (209,424) (200) 383,719
Balance at the beginning of the period at Mar. 31, 2018 387 606,584 (2,162) (239,052) (200) 365,557
Increase (decrease) in Stockholders' Equity            
Stock based employee compensation plan   160       160
New unrealized gain (loss) on investment securities, net of deferred tax expense (benefit)     (11,230)     (11,230)
Net income       14,454   14,454
Balance at the end of the period at Jun. 30, 2018 387 606,744 (13,392) (224,598) (200) 368,941
Increase (decrease) in Stockholders' Equity            
Stock based employee compensation plan   161       161
New unrealized gain (loss) on investment securities, net of deferred tax expense (benefit)     (557)     (557)
Net income       15,174   15,174
Balance at the end of the period at Sep. 30, 2018 387 606,905 (13,949) (209,424) (200) 383,719
Balance at the beginning of the period at Dec. 31, 2018 389 607,260 (22,315) (195,304) (200) 389,830
Increase (decrease) in Stockholders' Equity            
Stock based employee compensation plan   77       77
New unrealized gain (loss) on investment securities, net of deferred tax expense (benefit)     27,752     27,752
Equity distribution   (4,174)       (4,174)
Net income       13,440   13,440
Balance at the end of the period at Mar. 31, 2019 389 603,163 5,437 (181,864) (200) 426,925
Balance at the beginning of the period at Dec. 31, 2018 389 607,260 (22,315) (195,304) (200) 389,830
Increase (decrease) in Stockholders' Equity            
Net income           30,370
Balance at the end of the period at Sep. 30, 2019 430 661,357 33,930 (164,934) (200) 530,583
Balance at the beginning of the period at Mar. 31, 2019 389 603,163 5,437 (181,864) (200) 426,925
Increase (decrease) in Stockholders' Equity            
New unrealized gain (loss) on investment securities, net of deferred tax expense (benefit)     23,407     23,407
Net income       8,618   8,618
Balance at the end of the period at Jun. 30, 2019 389 603,163 28,844 (173,246) (200) 458,950
Increase (decrease) in Stockholders' Equity            
Stock based employee compensation plan   6,785       6,785
New unrealized gain (loss) on investment securities, net of deferred tax expense (benefit)     5,086     5,086
Proceeds from common stock sold in initial public offering, net of offering costs 42 51,557       51,599
Shares cancelled (1) 1        
Retirement of common stock (tax payments on equity compensation)   (149)       (149)
Net income       8,312   8,312
Balance at the end of the period at Sep. 30, 2019 $ 430 $ 661,357 $ 33,930 $ (164,934) $ (200) $ 530,583